Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study.
|
30799974 |
2019 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
|
31746956 |
2019 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Several genetic variants of LOX-1 are associated with the risk and severity of coronary artery disease.
|
30381837 |
2019 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Soluble LOX-1 (sLOX-1), a fragment of the main LOX-1 molecule, is being investigated as a diagnostic marker because it has been shown to be present in increased quantities in patients with hypertension, diabetes, metabolic syndrome and coronary artery disease.
|
31336709 |
2019 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Are IVS4 SNPs of OLR1 gene associated with coronary artery disease: Is there a linkage between IVS4 SNPs?
|
29558038 |
2018 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Also, it indicated that sodium/hydrogen exchanger 3 (SLC9A3), Prostaglandin G/H synthase 2 (PTGS2), Oxidized low-density lipoprotein receptor 1 (OLR1), and fibrinogen gamma chain (FGG) may be potential therapeutic targets for CHD.
|
28629174 |
2017 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
|
28941610 |
2017 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that antagonism between SRSF1 and SRSF2/HMGA1, and differential recognition of their regulatory motifs depending on the identity of the rs3736234 polymorphism, influence OLR1 exon 5 inclusion and the efficiency of Ox-LDL uptake, with potential implications for atherosclerosis and coronary disease.
|
25904137 |
2015 |
Coronary heart disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Many authors have shown the possibility to use LOX-1 as a good marker for the diagnosis and prognosis of coronary artery disease because it is easy to measure and more sensitive than other markers commonly used in the routine of laboratory medicine.
|
23934117 |
2013 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients.
|
21901421 |
2012 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Is LOX-1 K167N polymorphism protective for coronary artery disease?
|
20023241 |
2010 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Several studies have been carried out to explore the role of OLR-1 gene polymorphisms in the risk of coronary artery disease.
|
20136518 |
2010 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease.
|
16251892 |
2006 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
|
16829343 |
2006 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.
|
12810610 |
2003 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Manipulating LOX-1 activity might be a useful therapeutic and preventative approach for coronary artery disease, especially for individuals with the G501C genotype of OLR1.
|
12646194 |
2003 |